epub ahead of print

Minimal clinically important improvement and patient acceptable symptomatic state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: The reflect multinational study / Tubach, F., Ravaud, P., Martin Mola, E., Awada, H., Bellamy, N., Bombardier, C., Felson, D., Hassouni, N., Hochberg, M., Logeart, I., MATUCCI CERINIC, M., van de Laar, M., van der Heijde, D., Dougados, M.. - In: ARTHRITIS CARE & RESEARCH. - ISSN 2151-464X. - XXX:(2012), pp. XXX-XXX. [10.1002/acr.21747]

Minimal clinically important improvement and patient acceptable symptomatic state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: The reflect multinational study

MATUCCI CERINIC, MARCO;
2012-01-01

Abstract

epub ahead of print
2012
XXX
XXX
XXX
Minimal clinically important improvement and patient acceptable symptomatic state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: The reflect multinational study / Tubach, F., Ravaud, P., Martin Mola, E., Awada, H., Bellamy, N., Bombardier, C., Felson, D., Hassouni, N., Hochberg, M., Logeart, I., MATUCCI CERINIC, M., van de Laar, M., van der Heijde, D., Dougados, M.. - In: ARTHRITIS CARE & RESEARCH. - ISSN 2151-464X. - XXX:(2012), pp. XXX-XXX. [10.1002/acr.21747]
none
14
info:eu-repo/semantics/article
262
Tubach, F; Ravaud, P; Martin Mola, E; Awada, H; Bellamy, N; Bombardier, C; Felson, D; Hassouni, N; Hochberg, M; Logeart, I; MATUCCI CERINIC, Marco; va...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/154333
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 350
  • ???jsp.display-item.citation.isi??? 359
social impact